Exelixis
EXEL
#1760
Rank
NZ$20.63 B
Marketcap
NZ$76.64
Share price
-0.25%
Change (1 day)
20.82%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company